This population-based study highlights increasing ET prevalence and evolving treatment patterns in Taiwan, with tentative sex-based differences in age distribution and therapeutic response. Findings underscore the need for individualized, risk-adapted management and support ongoing surveillance to inform policy and clinical practice in Asian populations.
Lin et al. (Thu,) studied this question.